calender_icon.png 17 January, 2026 | 4:14 PM

Medicover Cancer Institute treats rare brain disease

15-01-2026 12:00:00 AM

Medicover Cancer Institute on Wednesday successfully treated a rare and high-risk brain condition — Pontine Cavernoma with hemorrhage — for a 57-year-old patient Ambati Ramulu, using advanced Stereotactic Radiosurgery (SRS), avoiding the need for high-risk open brain surgery. The patient had double vision and restricted eye movements. Detailed evaluation with MRI Brain revealed a pontine cavernoma, a condition caused by abnormal blood vessel formation in the brain. 

Considering the sensitive location, the medical team opted for SRS, a non-invasive radiation technique that delivers focused radiation to the lesion while sparing surrounding healthy brain tissue.

The treatment was performed as an outpatient procedure, and the patient was discharged in stable condition on the same day of his final session.

Speaking on the occasion, Dr. Kandra Prasanth, Consultant Radiation Oncologist, Medicover Cancer Institute, said that Stereotactic Radiosurgery offers a safe and effective alternative for patients where surgery carries high risk.

Doctors added that SRS is particularly beneficial for deep-seated brain lesions that cannot be safely operated upon, offering patients a safer, surgery-free treatment option with excellent outcomes.